Anti-angiogenic activity of ursodeoxycholic acid and its derivatives

Cancer Letters

Volumn 113, Issue 1-2, 1997, Pages 117-122

  Suh, Hongsuk ^a   Jung, Eun Jin ^a   Kim, Tae Hyong ^a   Lee, Ho Young ^a   Park, Yoo Hoi ^a   Kim, Kyu Won ^a  

^a Pusan National University   (South Korea)

Author keywords

Angiogenesis; Chorioallantoic membrane; Ursodeoxycholic acid

Indexed keywords

ANGIOGENESIS INHIBITOR; GLYCINE METHYL ESTER; HS 1030; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CATTLE; CELL VIABILITY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY;

ANIMALS; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; ENDOTHELIUM, VASCULAR; EXTRAEMBRYONIC MEMBRANES; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY ARTERY; URSODEOXYCHOLIC ACID;

ANIMALIA; BOS TAURUS;

EID: 0031586749     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04604-1     Document Type: Article

References (13)

1. [1] Crum, R., Szabe, S. and Folkman, J. (1985) A new class of steroids inhibits angiogenesis in the presence of heparin fragment, Science, 230, 1375-1378.
2. [2] Fett, J.W., Strydol, D.J., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F. and Vallee, B.L. (1985) Isolation and characterization of angiogenic, an angiogenic protein from human carcinoma cells, Biochemistry, 24, 5480-5486.
3. [3] Folkman, J. and Klagsburn, M.(1987) Angiogenic factor. Science, 235, 442-447.
4. [4] Gerald, A. and David, J.W. (1990) Regulation and ligand-binding specificities of two bile acid-binding proteins of rat liver cytosol, J. Biol. Chem., 265, 5654-5661.
5. [5] Gill, J.F. Jr., Kennenlly, P.J. and Rodwell, V.W. (1985) Sterols and Bile Acids. Elsevier, New York.
6. [6] Liotta, L.A., Kleineman, J. and Saidal, G.M. (1974) Quantitative relationship of intravascular tumor cell, tumor vessels, and pulmonary metastases following tumor implantation, Cancer Res., 34, 997-1004.
7. [7] Meeks, R.G., Zaharevitz, D. and Chen, R.F. (1981) Membrane effects of retinoids; possible correlation with toxicity, Arch. Biochem. Biophys., 207, 141-147.
8. [8] Moses, M.A., Sudhalter, J. and Langer, R. (1990) Identification of an inhibitor of neovascularization from cartilage, Science, 248, 1408-1410.
9. [9] Okikawa, T., Hasegawa, M., Simamura, M., Ashino-Fuge, H., Murota, S.I. and Morita, I. (1991) Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor, Biochem. Biophys. Res. Commun., 181, 1070-1076.
10. [10] Oikawa, T., Hirotani, K., Ogasawara, H., Katayama, T., Nakamura, O., Iwaguchi, T. and Hiragun, A. (1990) Inhibition of angiogenesis by vitamin D3 analogues, Eur. J. Pharmacol., 178, 247-250.
11. [11] Sohn, K.H., Lee, H.Y., Chung, H.Y., Young, H.S., Yi, S.Y. and Kim, K.W. (1995) Anti-angiogenic activity of triterpene acids, Cancer Lett., 94, 213-218.
12. [12] Still, W.C., Kahn, M. and Mitra, A. (1978) Rapid Chromatographic technique for preparative separation with moderate resolution, J. Org. Chem., 43, 2923-2925.
13. [13] Suh, H., Kim, K.W. and Suh, C.Y. (1995) Anti-Angiogenesis Inhibitors: Ursodeoxycholic Acid and its Derivatives. Korean Patent Appl. no. 1995-9440.